Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

about

Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals Chronic Hepatitis C Association with Diabetes Mellitus and Cardiovascular Risk in the Era of DAA Therapy

P2860

Q58584900-D52F9518-CBA4-400D-A9F0-02CFD3C531A2 Q58785077-22868802-6F68-436E-B146-41AC81BBC298

P2860

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

Item

http://www.wikidata.org/entity/Q47596049

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@en

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@nl

type

Item

label

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@en

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@nl

prefLabel

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@en

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c.

@nl

P1476

Hepatitis C Treatment with Sof ...... Improvement in Hemoglobin A1c

@en

P2093

Atsushi Takai

http://www.w3.org/2001/XMLSchema#string

Atsuyuki Ikeda

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Kokuryu

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Marusawa

http://www.w3.org/2001/XMLSchema#string

Kaori Ikeda

http://www.w3.org/2001/XMLSchema#string

Ken Takahashi

http://www.w3.org/2001/XMLSchema#string

Nobuya Inagaki

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

The lipid droplet is an important organelle for hepatitis C virus production

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.

Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.

Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.

Hepatitis C eradication with sofosbuvir leads to significant metabolic changes.

APASL consensus statements and recommendation on treatment of hepatitis C.

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.

Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.

Hepatitis C virus infection and incident type 2 diabetes.

P304

228-230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000484237

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoshihide Ueda

Hiroshi Seno

P577

2017-10-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29084399

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

about

P2860

P2860

Hepatitis C Treatment with Sofosbuvir and Ledipasvir Accompanied by Immediate Improvement in Hemoglobin A1c.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921